Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04382365 · ClinicalTrials.gov registry record · NA

Use of an Internet-Based Insomnia Intervention to Prevent Cognitive Decline in Adults With Mild Cognitive Impairment

A NA study of Mild Cognitive Impairment and Insomnia, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT04382365: Completed NA study of Mild Cognitive Impairment and Insomnia, sponsored by University of Virginia.

NCT04382365 is a NA study of Mild Cognitive Impairment and Insomnia that has completed, run by University of Virginia. The registered enrollment target is 12 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04382365, a NA study of Mild Cognitive Impairment and Insomnia, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine feasibility of an online program providing cognitive behavioral therapy for insomnia in adults with cognitive impairment. The study involves the use an Internet program (website) for 9 weeks. There are two required study visits in the home or in a UVA clinic. Participants will complete online questionnaires and sleep diaries twice during a 4-month period. Participants will also wear a sleep watch for two weeks before and after using the website.

Primary Outcome

Patient generated data on sleep through questionnaires

Interventions

  • OTHER Sleep Health Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness

Study Locations (1)

Virginia

  • University Of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-12-05
Est. Completion 2020-05-28
Phase NA
University of Virginia

449 total trials

What the finished NCT04382365 record still lists

NCT04382365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Sleep Health Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness is the first listed.

NCT04382365 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT04382365 about?

NCT04382365 is a clinical study titled "Use of an Internet-Based Insomnia Intervention to Prevent Cognitive Decline in Adults With Mild Cognitive Impairment". The purpose of the study is to determine feasibility of an online program providing cognitive behavioral therapy for insomnia in adults with cognitive impairment. The study involves the use an Internet program (website) for 9 weeks. There are two required study visits in the home or in a UVA clinic...

What is the current status of trial NCT04382365?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-12-05. Estimated completion is 2020-05-28.

What conditions does trial NCT04382365 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Insomnia, Cognitive Impairment.

What interventions are being tested in trial NCT04382365?

The interventions under investigation include: Sleep Health Using the Internet for Older Adult Sufferers of Insomnia and Sleeplessness (OTHER).

Who is sponsoring clinical trial NCT04382365?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04382365 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04382365's enrollment target sits among peer trials

12 196th of 205 higher than 9 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04382365, the US trial registry maintained by the National Library of Medicine. NCT04382365 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.